ER study tests which stomach pain remedy works fastest

NCT ID NCT06241183

Recruiting now Symptom relief Sponsor: Stony Brook University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares intravenous famotidine (a stomach acid reducer) and oral antacids (like Maalox) for treating dyspepsia (stomach pain) in the emergency department. About 80 adults with upper abdominal pain will rate their pain every 15 minutes for an hour. The goal is to see which treatment provides faster and better pain relief.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Famotidine (IV) and Maalox/Mylanta (oral antacid)
What this could lead to: If this trial succeeds, it could show which treatment works faster and better for stomach pain in the emergency room, helping doctors choose the best option.
What could go wrong: This is a small, early-phase study with only 80 participants, so results may not apply to everyone. Both treatments are already approved, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACID REFLUX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

dyspepsia gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACID REFLUX DYSPEPSIA GERD

Contacts and locations

Locations

Stony Brook University Hospital
RECRUITING

Stony Brook, New York, 11794, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.